Skip to main content

WellDoc BlueStar

By Emily Olsen | 02:35 pm | September 22, 2021
The new clearance expands its insulin dosing support to bolus and premixed insulin titration for Type 2 diabetes.
By Dave Muoio | 03:51 pm | June 03, 2020
Healthcare providers use a web interface to prescribe an initial dose "and BlueStar does the rest," according to Welldoc's chief medical officer.
By Dave Muoio | 05:06 pm | March 12, 2020
Also: Consumer survey suggests declining digital health engagement; Iran's COVID-19 app pulled from Play Store after malware accusations.
By Dave Muoio | 01:00 pm | November 05, 2019
This is the seventh FDA clearance for the longstanding mobile diabetes management platform.